New York, NY (May 1-6, 2004) — Experts in the field of psychiatry from NewYork-Presbyterian Hospital will present new developments in the areas of education, clinical care and research at the 157th annual American Psychiatric Association meeting beginning May 1.
NewYork-Presbyterian Hospital is ranked among the top two psychiatric institutions in the United States, according to US News & World Report. As one of the largest health care institutions in the world, NewYork-Presbyterian Hospital houses a psychiatry department with more than $100 million in research programs, nearly 400 inpatient psychiatric beds and extensive ambulatory services at sites in New York City and Westchester County, and two major residency programs.
Medical Experts who will present at the APA meeting include:
Dr. George S. Alexopoulos will review the neurobiologic basis of geriatric depression, including impaired neurotransmitters and pathways, and the rationale for developing drugs directed at neurotransmitter functions involved in geriatric depression.
Dr. Jack D. Barchas will receive the 2004 American Psychiatric Association (APA) Award for Research, the most significant award given for research by the APA. Following the awards ceremony, Dr. Barchas will deliver a lecture entitled "Adventures in Psychiatric Research: From Neurobiology to Public Policy." The speech will reflect Dr. Barchas' broad-based career as researcher, educator, institution builder, and as a craftsman of biomedical policy.
Dr. Barbara Bartlik — with Drs. Catherine Birndorf and James Kocsis, among others — will chair a symposium on "Women's Sexuality: Overcoming Obstacles to Pleasure." Among the areas explored will be effects of synthetic human pheromones on sexual behavior; sexual function in depressed patients, and the sexual side effects of antidepressants on female patients; changes in sexual arousal during pregnancy and across the menstrual cycle; new treatment options for women with sexual dysfunction, including over-the-counter oral supplements and topical creams; and the value of erotic videos in overcoming sexual problems and enhancing sexual relationships.
Dr. B. J. Casey will address three fundamental topics from her book on "Developmental Psychobiology": 1) the importance of both plasticity and stability in the development of behavioral and neural systems; 2) the establishment of typical and atypical developmental progressions in these systems; and 3) the impact of methodological advances in imaging and genetics on our understanding of typical and atypical behavioral and neural development.
Dr. Eric Collins, an expert in the treatment of substance abuse, will chair a discussion on "Anti-Craving Medication: A New Class of Psychoactive Medication?"
Dr. Roy Gulick, a specialist in HIV/AIDS, will discuss, with psychiatrist Dr. Stephen Ferrando, "What Every Psychiatrist Needs to Know About HIV."
Dr. Katherine Halmi will present on cognitive behavioral therapy for anorexia nervosa patients, and discuss problems of treatment acceptance by these patients.
Dr. Richard Hersh, along with legal professionals, will conduct a course entitled "Contemporary Malpractice Liability: A Practical Guide." Dr. Hersh will discuss psychiatric malpractice and borderline personality disorder.
Dr. Richard Kogan, an award-winning concert pianist as well as a psychiatrist, will explore the evidence for whether Beethoven suffered from mental illness, and will attempt to demonstrate the connections between Beethoven's psyche and his creative output.
Dr. Frances Levin will discuss the prevalence of adult attention deficit disorder in substance abusers.
Dr. John Markowitz, in a paper entitled "Longitudinal Comparison of Depressive Personality Disorder and Dysthymic Disorder," will distinguish between the two diagnoses, which formerly had been seen to be much more overlapping and inseparable. Additionally, he will chair a symposium on "Interpersonal Psychotherapy (IPT): Research Update," which will describe some of the new advances in this field.
Dr. David McDowell will discuss substance abuse and chemical dependence: "Ethical Dilemmas in Practice and Research"; "Why Does the Human Brain Become Addicted?"; "Buprenorphine Therapy: What the Clinician Should Know"; "Choosing the Best Treatment for Substance Abuse"; and "Cognitive Functioning: Predictors of Outcome."
Dr. Barnett S. Meyers will chair and discuss a session on "Psychotic Depression in 2004: The NIMH Collaborative Severe Depression Study."
Dr. Robert Michels will lead a discussion group on "Who Should Be Psychoanalyzed?" Additionally, he will participate in presentations on "Evidence-Based Psychotherapies" and "Wherefore Neuroscience: How Much Does the Psychiatrist Need to Know?"
Dr. Herbert Pardes, President and CEO of NewYork-Presbyterian Hospital and professor of psychiatry, will chair, as he has for many years, the traditional session on "Research Advances."
Dr. Cynthia Pfeffer will discuss the topic "Developmental Issues of the 'No Suicide Contract' in Children and Adolescents."
Dr. Steven Roose, an expert in the treatment of depression, will present "The Future of Treatment-Matching in Depression," a discussion about antidepressant medications and predictors of treatment response.
Dr. Saul Scheidlinger will co-chair a workshop on "Group Interventions with Adolescents in Outpatient, Inpatient and School Settings," and present at a workshop on "Milieu Therapies in the Age of Managed Care Revisited."
Dr. Mary S. Sciutto will present a workshop that focuses on the training of future psychiatrists in six key areas: medical knowledge; patient care; practice-based learning and improvement; interpersonal and communication skills; professionalism; and system-based practice at academic medical centers.
Dr. Philip Wilner, Vice Chairman of the Department of Psychiatry, will be elected a Fellow to the APA.
Society of Biological Psychiatry 2004 Annual Meeting
Neuroplasticity: The Effects of Psychiatric Illness and Treatment
NEW YORK (April 29-May 1, 2004) — Experts in biological psychiatry will explore what is known about the "neurocircuitry" of major psychiatric disorders, the effect on brain structure, and the impact on treatment interventions at the SBP annual meeting this week.
Dr. John J. Mann of NewYork-Presbyterian/Columbia is co-chair of the plenary session and will present a lecture on "Disordered Neurocircuitry in Depression."
Office of Public Affairs
pr@nyp.org